According to a statement from manufacturer Bristol-Myers Squibb, the voluntary recall is a “precautionary” measure after a customer complained that an apixaban (Eliquis) bottle labeled as containing ...

Eliquis 5 mg tablets are packaged in 60-count bottles, lot HN0063, Exp 09/2019, NDC 0003-0894-21. The recalled lot was distributed Nationwide in the U.S. to wholesalers and retail pharmacies in ...

Eliquis 5- and 2.5-mg tablets The recalled lot is HN0063, Exp 09/2019, NDC 0003-0894-2 and was distributed in February 2017 to wholesalers and retail pharmacies across the US.

IMPORTANT SAFETY INFORMATION for ELIQUIS ® (apixaban) 2.5 mg and 5 mg tablets WARNING: DISCONTINUING ELIQUIS IN PATIENTS WITHOUT ADEQUATE CONTINUOUS ANTICOAGULATION INCREASES RISK OF STROKE.

The company is voluntarily recalling one lot of Eliquis after a patient discovered that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. Bristol-Myers Squibb (BMS) is ...

According to the Food and Drug Administration, a bottle was mistakenly labeled as 5 mg doses when the bottle really contained only 2.5 mg tablets.

FDA Accepts Eliquis® (apixaban) Supplemental New Drug Application for Review for Prophylaxis of Deep Vein Thrombosis Following Hip Or Knee Replacement Surgery PRINCETON, N.J. & NEW YORK-- ...

UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation ELIQUIS Demonstrated Superior ...

Eliquis tablets 2.5 mg and 5 mg had annual sales of approximately $6,366 million in the US, Lupin added.

Shares of pharma major Lupin was down 1.5 percent intraday Tuesday. The company has received tentative approval for its Apixaban tablets, 2.5 mg and 5 mg from the United States Food and Drug ...